Delivery Order SPE2DB24D2215-SPE2DB25FGRXK

Award Date 10/15/24
Potential Completion Date 11/5/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ingrezza 40 mg capsules. The fixed-price delivery order is valued at $3,553.31 and has an ultimate completion date of August 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, to provide a comprehensive range of medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules. The contract has a ceiling value of $11,679.45 and an ultimate completion date of August 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription medications to support various government healthcare programs, including military treatment facilities and veterans' hospitals nationwide. The contract is not set...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Ingrezza 80 mg capsules. The contract has a total ceiling value of $3,893.15 and a period of performance through April 1, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which was not set aside for any specific business category. AmerisourceBergen Drug Corp holds an Indefinite...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of Ingrezza 40 mg capsules. The $3,119.55 firm fixed-price delivery order has an ultimate completion date of April 10, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Ingrezza 40 mg capsules. The contract has a ceiling value of $7,106.64 and an ultimate completion date of August 7, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the federal government, was awarded this firm-fixed-price delivery order to provide the prescription medication to support military treatment facilities and other...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of INGREZZA 80 MG CAPSULE 30S. The order has a firm fixed price of $3,714.98 and a completion date of February 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,553.31, is for the delivery of 4565242920 INGREZZA 40 MG CAPSULE 30S. The contract is a firm fixed-price delivery order with an ultimate completion date of August 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ingrezza 40 mg capsules. The contract has a total ceiling value of $3,119.55 and an ultimate completion date of April 15, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered as a federal contractor. The contract is a firm-fixed-price delivery order, with no set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,338.12, is for the delivery of Ingrezza 80 mg capsules. The contract has an ultimate completion date of March 21, 2023 and is a firm fixed-price contract. The contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a for-profit...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,676.12 contract is for the supply of Ingrezza 40 mg capsules, a medication used to treat tardive dyskinesia. The contract has an ultimate completion date of February 4, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a $999,999,999...
  • SPE2DB24D2215
    Indefinite Delivery Contract
  • SPE2DB24D2215-SPE2DB25FGRXK
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ingrezza 60 mg capsules. The order has a firm fixed price of $3,914.32 and an ultimate completion date of November 5, 2024. This contract is not set aside for any specific business type. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000, respectively, to provide a wide range of pharmaceutical and medical supplies to support military treatment programs, veterans' healthcare, and other federal healthcare needs.

Generated 1/14/25, 9:23 AM